Home

Chest guidelines VTE prophylaxis PDF

Antithrombotic Therapy for VTE Disease - Ches

Prevention of VTE in Nonorthopedic Surgical Patients - Ches

  1. This article discusses the prevention of venous thromboembolism (VTE) and is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits do or do not outweigh risks, burden, and costs
  2. of VTE during hospitalization and to provide recommended therapy options for extended VTE prophylaxis after hospital discharge. Target Population: The recommendations within this guideline would apply to any adult inpatient with the intent to remain hospitalized for greater than 24 hours or who are discharged on extended VTE prophylaxis
  3. www.chestpubs.org CHEST / 141 / 2 / FEBRUARY, 2012 SUPPLEMENT e197S This article focuses on prevention of VTE in non-surgical populations. Because they are addressed in other chapters in these guidelines, 1,2 we do not include prevention of VTE in patients with trauma and spinal cord injury and in patients with ischemic and hemorrhagic stroke
  4. Prevention of VTE in Nonsurgical Patients - CHEST. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only Articles | Volume 141, ISSUE 2, SUPPLEMENT , e195S-e226S, February 01, 2012
  5. D. CT angio Chest - filling defect(s) V. VTE Prophylaxis Protocol for Trauma Patients A. All trauma patients, unless otherwise specified, should receive VTE prophylaxis with at least enoxaparin (Lovenox) 30 mg SQ Q 12 hr within 24 hrs of admission (see Obesity and Weight-Based Dosing). a
  6. Note on Shaded Text: In this guideline, shaded text with an asterisk (shading appears in PDF only) indicates recommendations that are newly added or have been changed since the publication of Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis (9th edition): American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
  7. ceived VTE prophylaxis at admission if they had evidence of receipt of any of the above-mentioned agents or modalities on either day 1 or day 2 in the hospital.10 Patients who began VTE prophylaxis later WHAT IS KNOWN • Although venous thromboembolism (VTE) risk is substantially higher in patients undergoing majo

  1. Perioperative VTE prophylaxis in major surgery in general 1. Pharmacological prophylaxis vs mechanical prophylaxis 2. Mechanical prophylaxis vs no prophylaxis 3. Pneumatic compression devices vs graduated compression stockings 4. Pharmacological prophylaxis combined with mechanical prophylaxis vs pharmacological prophylaxis alone 5
  2. VTE is a major cause of sudden death in hospitalized patients. The difficulty of early diagnosis due to vague symptomatology. Pharmacologic prophylaxis reduces the incidence of VTE. VTE prophylaxis is cost‐effective. Arch Intern Med 1991;151:933‐8 JAMA 1987; 257:203-20
  3. list improved prophylaxis for VTE as a top 10 patient safety strategy to act on now.35 The American Public Health Association has stated that the disconnect between evidence and execution as it relates to DVT prevention amounts to a public health crisis. 3
  4. 4. Approach to VTE prophylaxis in the hospital after vaginal delivery: Approach to Venous Thromboembolism (VTE) Prophylaxis after Vaginal Delivery Risk Category Clinical Situation Recommendation for pharmacologic or mechanical VTE prophylaxis Laboratory studies prior to and after initiation of treatment/prophylaxis Extremely high risk 1
  5. Bleeding after VTE Prophylaxis in General Surgery Meta-analysis: 52 RCTs of VTE prophylaxis in 33,813 pts Prophylaxis Control Injection site bruising 6.9% 2.8% Wound hematoma 5.7% 0.8% Drain site bleeding 2.0% 0.6% Hematuria 1.6% 0 GI bleeding 0.2% 1.9% Retroperitoneal bleeding < 0.1%

The prevention of VTE, or VTE prophylaxis, is an important patient safety strategy in hospital settings where patients are at risk of developing VTE.(2) Purpos added as options for VTE prophylaxis and treatment. GUIDELINE QUESTIONS This clinical practice guideline addresses six clinical questions: 1. Should hospitalized patients with cancer receive anticoagulation for VTE prophylaxis? 2. Should ambulatory patients with cancer receive anticoagulation for VTE prophylaxis during sys-temic chemotherapy? 3 venous thromboembolism, 8. th. ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133:381S-453S. 4. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. CHEST Supplement www.chestpubs.org CHEST / 141 / 2 / FEBRUARY, 2012 SUPPLEMENT 7S ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES The eighth iteration of the American College of Chest Physicians Antithrombotic Guidelines pre-sented, in a paper version, a narrative evidence sum

Prevention of VTE in Nonsurgical Patients - CHES

Many medical societies have created CPG for VTE prophylaxis in orthopedic surgery, including after TJA and HFS. Guidelines from the American Academy of Orthopedic Surgeons, the American College of Chest Physicians, the National Institute for Health and Care Excellence from the Department of Health in England, and the American Society of Hematology are summarized in Table 1 • Pregnancy - DVT, PE, prophylaxis for antithrombin deficiency, or prior pregnancy VTE: LMWH [I C]. • Active cancer and either just diagnosed, extensive symptoms, metastatic cancer, vomiting, on chemo therapy

Current ACCP guideline recommendations on the need for VTE prophylaxis in an individual patient focus on that patient's risk for developing VTE.4 This assessment of a patient's risk is based on a number of risk factors that have been identified from epidemiologic studies. Some of the more defined risk factors are briefly summarized in the. Practice Management Guidelines for Prevention of Venous Thromboembolism in Trauma Patients: the EAST Practice Management Guidelines Work Group. Journal of Trauma. 2002;53(1):142-164. 10. Prophylaxis for Venous Thromboembolism in Trauma and Neurosurgical Patients. Sunnybrook Health Sciences Centre, University of Toronto. 2011. 11 CHEST hosts a discussion with the authors upon release of a guideline, to add context and commentary to the issues and challenges facing clinicians. Antithrombotic Therapy for VTE Disease: CHEST Guideline (February 2016) Duration: 33 min Moderator: Ian T. Nathanson, MD, FCCP, Section Editor, CHEST

Antithrombotic Therapy for VTE Disease - CHES

VTE prophylaxis (LDH and/or SCD), and had weekly Duplex scan. 26 develope d proximal DVT (13%), 4 PE (2%). Risk factors for DVT were severe chest injuries, extremity fractures, and high levels of PEEP during mechanical support. Spain DA et al 7 1997 Venous thromboembolism in the high-risk trauma patient: do risks justify aggres sive screening an guidelines are very useful resources and generally reflect the accepted standard of practice. TESTS FOR COMPLIANCE Major There is a written venous thromboembolism (VTE) prophylaxis policy or guideline. Major Clients at risk for VTE are identified and provided with appropriate, evidence-informed VTE prophylaxis dations from guidelines. Most of the recommendations are based on the 10th edition of the American College of Chest Physicians (ACCP) guidelines on antithrombotic therapy for VTE disease (Table 1).1- n 2012, the American College of Chest Physicians (ACCP) developed guidelines for the prevention and treatment of venous thromboembolism (VTE)1,2 in adults, children,andpregnantwomen.3-7 Inthe2008iterationofthe ACCP guidelines,8 inflammatory bowel disease (IBD) was specifically mentioned as a risk factor for VTE, but this wa

prophylaxis after THA, TKA, and HFS, brought the ACCP CPG into alignment with the AAOS clinical practice guideline [2]. This alignment between AAOS and ACCP resulted in aspirin being included as an acceptable prophylactic option under the Surgical Care Improvement Project (SCIP) Venous Thromboembolism (VTE) quality measure beginning January 1. Guidelines Time for an Update? A Look at Current Guidelines for Venous Thromboembolism Prophylaxis After Hip and Knee Arthroplasty and Hip Fracture Stefano R. Muscatelli, MD a, Michael A. Charters, MD b, Brian R. Hallstrom, MD a, c, * a Department of Orthopaedic Surgery, University of Michigan Health System, Ann Arbor, MI, US Offer VTE prophylaxis where appropriate. Do not offer pharmacological VTE prophylaxis if the patient has any risk factor for bleeding and risk of bleeding outweighs risk of VTE. Reassess the risks of VTE and bleeding within 24 hours of admission and whenever the clinical situation changes

Prophylaxis Against Venous Thromboembolism in Hospitalized

Venous Thromboembolism 16-3 . 16.1 Patient Safety Practice: Use of Aspirin for VTE Prophylaxis 16.1.1 Practice Description As VTE, in particular DVT, can be very difficult to diagnose, actively employing prevention techniques i Physicians Evidence-Based Clinical Practice Guidelines 2012 guidelines (CHEST) were documented.13 The primary outcome was to describe the use of VTE prophylaxis in CLD patients. Secondary out-comes were to determine the overall incidence of VTE in CLD patients, examine the incidence of VTE based on the utilization of prophylaxis, compare the occur Venous thromboembolism prophylaxis in liver surgery. Journal of Gastrointestinal Surgery, 20(1), 221- 229. Falck-Ytter, Y., et al. (2012). Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: A merican College of Chest Physicians evidence- based clinical practice guidelines. Chest, 141(2), e278S.

Chest Physicians Evidence-Based Clinical Practice Guidelines Chest. VTE_Prophylaxis_Guidelines.pdf Read/Download File Report AbuseAmerican Academy of Orthopaedic Surgeons Peer - AAHKS.orgVenous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review. Update because:. ACCP Guidelines on Prevention of VTE in Orthopedic Surgery Patients, 9th ed. 2.1.1 & 2.1.2. For THA or TKA recommend one of following rather than no prophylaxis for minimum of 10 • venous thromboembolism* * The Queensland Health statewide guideline for the prevention of VTE in adult hospitalised patients describes all major trauma patients being at immediate high VTE risk and provides recommendations for both pharmacological and mechanical VTE prophylaxis from the point of admission.4

To outline the recommended approach to venous thromboembolism (VTE) prophylaxis for all patients admitted to an Alberta Health Services acute and sub-acute care facility. Clinical judgment may be exercised when a situation is determined to be outside the parameters provided in this guideline. If a deviation from this guideline is determined to b The American College of Chest Physicians (ACCP) regularly publishes evidence-based recommendations from a panel of experts covering the full spectrum of venous thromboembolism (VTE) prevention, diagnosis, and management [].The ACCP guidelines review and assess the available clinical evidence, and present recommendations graded according to the risk-benefit assessment made by the expert panel Guidelines. CHEST, 141(2), February 2012 Supplement, p195S-226S. Larkin BG, Mitchell KM. Translating Evidence to Practice for Mechanical Venous Thromboembolism Prophylaxis. AORN Journal, November 2012, 96(5) p 513-27. Maynard G, Stein J. Preventing Hospital-Acquired Venous Thromboembolism. A Guide for Effective Quality Improvement, 2008 The 2004 American College of Chest Physicians (ACCP) evidence-based consensus guidelines were used to assess VTE risk and to determine whether patients were receiving recommended prophylaxis. 68.

ASH Clinical Practice Guidelines on VTE 1. Prevention of VTE in Surgical Hospitalized Patients 2. Prophylaxis in Hospitalized and Non -Hospitalized Medical Patients 3. Treatment of Acute VTE (DVT and PE) 4. Optimal Management of Anticoagulation Therapy 5. Prevention and Treatment of VTE in Patients with Cancer 6. Heparin-Induced. To develop guideline recommendations for the use of anticoagulation in the prevention and treatment of venous thromboembolism (VTE) in patients with cancer. Methods A comprehensive systematic review of the medical literature on the prevention and treatment of VTE in cancer patients was conducted and reviewed by a panel of content and methodolog In 2008, ACCP guidelines clearly recommended against the use of aspirin alone as VTE prophylaxis for any patient group, and therefore for any orthopaedic patient. 19 However, the 2012 ACCP guidelines do recommend the use of aspirin as VTE prophylaxis for patients undergoing THR, TKR or hip fracture surgery because it appeared that the use of. Venous Thromboembolism Prophylaxis in the Treatment of Foot and Ankle Disorders Stephan J. LaPointe, DPM, PhD Karen Moon, DPM INTRODUCTION Venous thromboembolism (VTE) consisting of both deep venous thrombosis (DVT) and pulmonary embolism (PE) rates are 1 to 2 per 1,000 person-years and increases with age to 1% per year (1)

American Society of Hematology 2019 guidelines for

Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P. Venous thromboembolism prophylaxis in hospitalised patients: a clinical practice guideline from the American College of Physicians. Ann Intern Me Guidelines & Topic Collections. Everything we publish is designed to keep you up‑to‑date on the latest news, approaches, and ideas in chest medicine. From the most relevant research findings to the most significant clinical guidelines, these are the highly accredited resources you count on from CHEST Venous Thromboembolism Prophylaxis and Screening • For nonhospitalized patients with COVID-19, anticoagulants and antiplatelet therapy should not be initiated for the prevention of venous thromboembolism (VTE) or arterial thrombosis unless the patient has other indications for the therapy or is participating in a clinical trial (AIII)

ASCO Venous Thromboembolism Prophylaxis and

In the American College of Chest Physicians (ACCP) guidelines on VTE prophylaxis in patients undergoing nonorthopedic surgery, the standard duration or limited duration of prophylaxis was not defined.4 However, extended duration pharmacologic prophylaxis was defined as fou Monagle P, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treat-ment of pediatric venous thromboembolism. Blood Adv 2018; 2 (22): 3292-3316. Monagle P, Chan A, Goldenberg NA, et al. Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical. Venous Thromboembolism Prophylaxis, Pediatric Trauma Patients - Joint between EAST and PTS 2017; Venous Thromboembolism, Adult Trauma Patients 2002; Venous Thromboembolism: Low Dose Heparin for DVT/PE Prophylaxis 2002; Venous Thromboembolism: Pneumatic Compression Devices in the Prevention of DVT/PE 200

Time for an Update? A Look at Current Guidelines for

Anti-Xa level and VTE incidence Despite the evidence that weight-based enoxaparin dosing improves the likelihood that patients will achieve a target anti-Xa level, it is unclear what anti-Xa level correlates with decreased VTE risk. This is explicitly acknowledged by the College of American Chest Physicians in their VTE prophylaxis guidelines (3) Background: Evidence-based guidelines recommend that acutely ill hospitalized medical patients who are at risk of venous thromboembolism (VTE) should receive prophylaxis. Our aim was to characterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patient Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020; 7(5): e362-3 Venous thromboembolism is a well-established complication of total hip and knee arthroplasty and hip fracture surgery. Clinical practice guidelines have been proposed to help clinicians provide prophylaxis against this risk. However, most guidelines reference data that are becoming outdated because of new advances in perioperative protocols. Recent data would suggest that aspirin may be.

Objective To determine the proportion of patients receiving venous thromboembolism (VTE) prophylaxis after oncological surgeries as per the hospital standards and its comparison with the international guidelines. Methodology In the month of September 2019, all patients after elective oncological surgeries were reviewed for VTE prophylaxis administration and education [Guideline] Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb. Nonpharmacologic agents such as graduated compression stockings and intermittent pneumatic compression (IPC) devices are not as effective as pharmacologic agents. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines

Table 4: VTE Prophylaxis Regimens in High VTE Risk Patients. 1,6-8,16,18-20 . Patient Population Weight VTE Prophylaxis Regimens Normal Renal Function <60 kg • Enoxaparin 0.5 mg/kg SQ every 12 hours (max 60 mg/day) a >60 kg • Enoxaparin 40 mg SQ every 24 hours. b (consider 30 mg SQ every 12 hours for total knee arthroplasty Venous thromboembolism (VTE) prophylaxis after total joint arthroplasty is considered best practice. However, over the past 5 years, there has been considerable debate about the ideal prophylactic regimen or modality. The American Academy of Orthopaedic Surgeons and the American College of Chest Physicians published their most recent clinical. Background: VTE is a common cause of preventable death in surgical patients. Methods: We developed recommendations for thromboprophylaxis in nonorthopedic surgical patients by using systematic methods as described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of.

Objective. Guidelines for pharmacologic obstetric venous thromboembolism (VTE) prophylaxis from the American Congress of Obstetricians (ACOG), the Royal College of Obstetricians and Gynaecologists (RCOG), and the American College of Chest Physicians (Chest) vary significantly Although a number of clinical practice guidelines have addressed the prevention and treatment of VTE, a number of controversial issues remain. These include risk stratification, the timing of initiation of prophylaxis, the optimal duration of prophylaxis, and the underutilization of means to prevent VTE

ACCP GUIDELINES DVT PROPHYLAXIS 2012 PDF - Chest. Feb;(2 Suppl):eS-eS. doi: /chest Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines. Antithrombotic Therapy, and Pregnancy February Recommendations focusing on the management of venous thromboembolism and thrombophilia. VTE is a common cause of preventable death in. Since the publication of the SAGES guidelines for venous thromboembolism (VTE) prophylaxis during laparoscopic surgery in 2007 [], the American College of Chest Physicians (ACCP) has published their comprehensive guidelines that address VTE prophylaxis for non-orthopedic surgery patients [].After careful review, the SAGES guidelines committee has approved the endorsement of the ACCP guidelines. Chest dvt prophylaxis guidelines 2012 pdf Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012; 141: e227S-e277SAntithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians (ACCP) guidelines for VTE prophylaxis recommend the use of these devices as an alternative to or in conjunction with anticoagulation therapy in 3 distinct populations: 1) nonsurgical patients, such as hospitalized medical patients; 2) nonorthopedic surgical patients

Video: Guidelines - American College of Chest Physician

Venous thromboembolism (VTE) prophylaxis - Guidelines

Guidelines on the use of prophylaxis in venous thromboembolism (VTE) are poorly implemented in clinical practice. To evaluate the extent to which the American College of Chest Physicians (ACCP. VTE: 2016 ACCP Update with Best Evidence and Best Practices Steven Deitelzweig, MD, MMM, SFHM Kearon C, et al. CHEST Guideline, Chest. 2016. outcome Out N=171 In N=168 Difference in %age p value Recurrent VTE 1 0 0.6% 0.01 Major bleed* 3 0 1.8% 0.0 VTE Prophylaxis Contraindicated, Reason: _____ Total Risk Factor Score Risk Level Prophylaxis Regimen 0 VERY LOW Early ambulation (Please refer to Dosing Guidelines on the back of this form) Joseph A. Caprini, MD, MS, FACS, RVT VTE Risk Factor Assessment Tool. PREGNANT PATIENT CHEST Consensus Guidelines 2012 Risk Caprini Score *VTE incidence Prophylaxis Very low 0 0.5% Early ambulation Low 1-2 1.5% IPC Moderate 3-4 3.0% LMWH, UFH,IPC High 5+ 6.0% LMWH, UFH + IPC or GS Gould, MK et al; CHEST 2012; 141(2)(Suppl):e227S-e277S *Estimated baseline risk in the absence of pharmacologic or mechanical prophylaxis VTE Guidelines: Prophylaxis for Medical Patients. Medical inpatients, long-term care residents, persons with minor injuries, and long-distance travelers are at increased risk of VTE, which can be fatal. Hospitalization for acute medical illness is an important opportunity for applying prevention efforts. These guidelines address methods to.

VTE Risk Profiles and Prophylaxis in Medical and Surgical

venous thromboembolism. The practitioner might further assess the risk of venous thromboembolism by determining whether these patients had a previous venous thromboembolism. Grade of Recommendation: Limited Description: Evidence from two or more Low strength studies with consistent findings, o Bottom line: Anticoagulant therapy recommendations have been updated, but few are strong recommendations and none are based on high-quality evidence. Citation: Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149 (2):315-352 Venous Thromboembolism Risk Assessment and Prophylaxis The National Quality Forum as part of the National Patient Safety Goal 03.05.01, mandates that all adult patients 18 years of age and older (exceptions include patients with behavior disorders, obstetrica Strong recommendations include the use of thrombolytic therapy for patients with PE and hemodynamic compromise, use of an international normalized ratio (INR) range of 2.0 to 3.0 over a lower INR range for patients with VTE who use a vitamin K antagonist (VKA) for secondary prevention, and use of indefinite anticoagulation for patients with recurrent unprovoked VTE method of prophylaxis for VTE. This guideline is based on the most recent recommendations from the American Association of Orthopedic Surgeons and the American College of Chest Physicians combined with current practices at VCMC. Total Knee Arthroplasty: Enoxaparin (Lovenox) 40mg SC daily or Fondaparinux (Arixtra) 2.5mg dail

The eighth American college of chest physicians guidelines

Venous thromboembolism (VTE) remains an immediate threat to patients following total hip and knee replacement. While there is a strong consensus that steps should be taken to minimise the risk to patients by utilising some forms of prophylaxis for the vast majority of patients, the methods utilised have been extremely variable VTE: Venous Thromboembolism, including deep vein thrombosis (of the limbs, abdomen, neck/chest, cranial), intracardiac thrombosis, and pulmonary embolism. INITIAL EVALUATION All patients should be assessed for VTE risk within 24 hours of admission and on a daily basis. Patients ar laparoscopic surgery in 2007 (1), the American College of Chest Physicians (ACCP) has published their comprehensive guidelines that address VTE prophylaxis for non-orthopedic surgery patients (2). After careful review, the SAGES guidelines committee has approved the endorsement of the ACCP guidelines rather than update our previous VTE guidelines European guidelines on perioperative venous thromboembolism prophylaxis: Aspirin. Eur J Anaesthesiol 2018; 35:123. Beyer-Westendorf J, Lützner J, Donath L, et al. Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry

ACCP ANTITHROMBOTIC GUIDELINES 9TH ED PDF

PDF | Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous. Background: VTE is a serious, but decreasing complication following major orthopedic surgery. This guideline focuses on optimal prophylaxis to reduce postoperative pulmonary embolism and DVT. Methods: The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of. NEW GUIDELINES for Management of Superficial Vein Thrombosis. In May 2015, new UWMedicine Guidelines for Management of Superficial Vein Thrombosis were approved. The new guidelines can be found in the VTE section of this website Venous Thromboembolism (VTE) Chemoprophylaxis . Clinical Practice Guideline . Original Date: 04/2003 Purpose: To define patient populations at increased risk for VTE. Supersedes: 10/2017 and administer appropriate prophylaxis. Last Review Date: 01/2019 . Recommendations for VTE Prophylaxis: 1